All In MedTech

Device Trial Radar · NCT00235157

A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.

Palmaz Genesis Peripheral Stainless Steel Balloon Expandable Stent, Comparing a Sirolimus Coated Versus an Uncoated Stent in REnal Artery Treatment.

Last checked: Nov 20, 2026Latest source record: Aug 6, 2008 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

105

Actual

Start

Nov 2001

Primary completion

Nov 2002

Study completion Jul 2005

Sponsor

Lead sponsor
Cordis US Corp.Not on our public-company list
Sponsor type
Industry
First posted
Oct 10, 2005

More device trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of this study is to compare the safety and performance of the Palmaz Genesis™ balloon expandable stent, with or without sirolimus coating in the treatment of renal artery stenosis, measured at 6 months follow up via angiography.

Conditions

  • Renal Artery Stenosis

Interventions

  • Sirolimus-eluting Palmaz Genesis peripheral stentDevice

    treatment of renal artery stenosis with a renal stent

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. assessment of the angiographical in-stent minimal lumen diameterTime frame: 6-months follow up

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Hopital Européen Georges Pompidou

    Paris, France

  • Universitätskliniken Köln

    Cologne, Germany

  • Erasmus MC Rotterdam

    Rotterdam, Netherlands

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.